Equities

Beijing Balance Medical Technology Co Ltd

688198:SHH

Beijing Balance Medical Technology Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)120.00
  • Today's Change-4.78 / -3.83%
  • Shares traded410.17k
  • 1 Year change-15.67%
  • Beta--
Data delayed at least 15 minutes, as of Nov 14 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CNYIncome statement in CNYView more

Year on year Beijing Balance Medical Technology Co Ltd grew revenues 25.57% from 295.17m to 370.64m while net income improved 21.09% from 95.14m to 115.21m.
Gross margin88.31%
Net profit margin22.42%
Operating margin25.99%
Return on assets7.14%
Return on equity8.90%
Return on investment7.46%
More ▼

Cash flow in CNYView more

In 2023, Beijing Balance Medical Technology Co Ltd increased its cash reserves by 130.76%, or 166.92m. The company earned 141.17m from its operations for a Cash Flow Margin of 38.09%. In addition the company generated 79.30m cash from investing, though they paid out 53.54m more in financing than they received.
Cash flow per share--
Price/Cash flow per share--
Book value per share8.53
Tangible book value per share7.59
More ▼

Balance sheet in CNYView more

Beijing Balance Medical Technology Co Ltd has little financial risk as the capital structure does not rely on leverage.
Current ratio8.99
Quick ratio8.22
Total debt/total equity0.0092
Total debt/total capital0.0091
More ▼

Growth rates in CNY

Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 60.00% and 19.79%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
Div yield(5 year avg)0.37%
Div growth rate (5 year)--
Payout ratio (TTM)105.51%
EPS growth(5 years)16.84
EPS (TTM) vs
TTM 1 year ago
-2.80
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.